Maria Donawa presented on EU/US differences at Vienna Conference on Clinical Studies

Donawa Lifescience President, Maria E. Donawa M.D., spoke at the ​2nd Conference on Clinical Studies with Medical Devices and IVDs, which took place in Vienna, Austria, on 30-31 March 2023. This year’s conference was designed to provide a wealth of information for both medical device and in vitro diagnostic clinical investigations, with a particular focus on practical methods and guidance on implementing regulatory requirements.

Dr. Donawa spoke at 11:30 on the first day, covering the topics of “Clinical Evidence for US Market Access” and “Why do Clinical Trials Leave the EU for the US?”

The Congress home page can be accessed  from here, and the program from here.